Stem Cell Gene Therapy For Fatal Childhood Disease Ready For Human Trial Friday, May 13, 2016 A pioneering approach for Sanfilippo disease, a genetic condition for which there is no effective treatment, will now be trialled in humans.Record £16.9m for OxStem Friday, May 13, 2016 One of the most ambitious Oxford spinouts to date is en route to becoming a powerhouse in age-related regenerative medicine, developing drugs which can treat cancer, neurodegenerative diseases, heart failure, macular degeneration and other major age-related conditions. Insulin-secreting Cells from Stem Cells Wednesday, May 11, 2016 Stem cells from diabetic patients coaxed to become insulin-secreting cells. If damaged cells are replaceable, type 1 diabetics wouldn't need insulin shots.How Skeletal Stem Cells Form The Blueprint Of The Face Friday, May 06, 2016 USC researchers discover that two types of molecular signals work to control where and when stem cells turn into facial cartilage.AACR 2016: Cancer Immunotherapy and Beyond Friday, May 06, 2016 At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).Turning Skin Cells into Heart, Brain Cells Tuesday, May 03, 2016 In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals. Stem Cells Know How to Unwind Tuesday, May 03, 2016 Research led by the Babraham Institute with collaborators in the UK, Canada and Japan has revealed a new understanding of how an open genome structure supports the long-term and unrestricted developmental potential in embryonic stem cells. Growing Stem Cells More Safely Tuesday, May 03, 2016 Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.Cell Transplant Treats Parkinson’s in Mice Friday, April 29, 2016 A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.